These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 8679291)

  • 21. N-linked glycosylation sites adjacent to and within the V1/V2 and the V3 loops of dualtropic human immunodeficiency virus type 1 isolate DH12 gp120 affect coreceptor usage and cellular tropism.
    Ogert RA; Lee MK; Ross W; Buckler-White A; Martin MA; Cho MW
    J Virol; 2001 Jul; 75(13):5998-6006. PubMed ID: 11390601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Small amino acid sequence changes within the V2 domain can affect the function of a T-cell line-tropic human immunodeficiency virus type 1 envelope gp120.
    Koito A; Stamatatos L; Cheng-Mayer C
    Virology; 1995 Feb; 206(2):878-84. PubMed ID: 7856100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A model for alignment of Env V1 and V2 hypervariable domains from human and simian immunodeficiency viruses.
    Lamers SL; Sleasman JW; Goodenow MM
    AIDS Res Hum Retroviruses; 1996 Aug; 12(12):1169-78. PubMed ID: 8844021
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of V2 mutations on escape from a potent neutralizing anti-V3 monoclonal antibody during in vitro selection of a primary human immunodeficiency virus type 1 isolate.
    Shibata J; Yoshimura K; Honda A; Koito A; Murakami T; Matsushita S
    J Virol; 2007 Apr; 81(8):3757-68. PubMed ID: 17251298
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human immunodeficiency virus envelope V1 and V2 regions influence replication efficiency in macrophages by affecting virus spread.
    Toohey K; Wehrly K; Nishio J; Perryman S; Chesebro B
    Virology; 1995 Oct; 213(1):70-9. PubMed ID: 7483281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glycan deletions in the HIV-1 gp120 V1/V2 domain compromise viral infectivity, sensitize the mutant virus strains to carbohydrate-binding agents and represent a specific target for therapeutic intervention.
    Auwerx J; François KO; Covens K; Van Laethem K; Balzarini J
    Virology; 2008 Dec; 382(1):10-9. PubMed ID: 18930512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cooperation of the V1/V2 and V3 domains of human immunodeficiency virus type 1 gp120 for interaction with the CXCR4 receptor.
    Labrosse B; Treboute C; Brelot A; Alizon M
    J Virol; 2001 Jun; 75(12):5457-64. PubMed ID: 11356952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determinants for the syncytium-inducing phenotype of HIV-1 subtype F isolates are located in the V3 region.
    Holm-Hansen C; Baan E; Asjö B; Pascu FR; Goudsmit J; De Jong JJ
    AIDS Res Hum Retroviruses; 2000 Jun; 16(9):867-70. PubMed ID: 10875612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sequence diversity of V1 and V2 domains of gp120 from human immunodeficiency virus type 1: lack of correlation with viral phenotype.
    Wang N; Zhu T; Ho DD
    J Virol; 1995 Apr; 69(4):2708-15. PubMed ID: 7884929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Envelope diversity, coreceptor usage and syncytium-inducing phenotype of HIV-1 variants in saliva and blood during primary infection.
    Freel SA; Fiscus SA; Pilcher CD; Menezes P; Giner J; Patrick E; Lennox JL; Hicks CB; Eron JJ; Shugars DC
    AIDS; 2003 Sep; 17(14):2025-33. PubMed ID: 14502005
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patterns of amino acid variability in NSI-like and SI-like V3 sequences and a linked change in the CD4-binding domain of the HIV-1 Env protein.
    Milich L; Margolin BH; Swanstrom R
    Virology; 1997 Dec; 239(1):108-18. PubMed ID: 9426451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV type 1 infection of CD4+ T cells depends critically on basic amino acid residues in the V3 domain of envelope glycoprotein 120.
    Okada T; Patterson BK; Otto PA; Gurney ME
    AIDS Res Hum Retroviruses; 1994 Jul; 10(7):803-11. PubMed ID: 7986586
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human immunodeficiency virus type 1 evasion of a neutralizing anti-V3 antibody involves acquisition of a potential glycosylation site in V2.
    Hatada M; Yoshimura K; Harada S; Kawanami Y; Shibata J; Matsushita S
    J Gen Virol; 2010 May; 91(Pt 5):1335-45. PubMed ID: 20032207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Functional complementation of the envelope hypervariable V3 loop of human immunodeficiency virus type 1 subtype B by the subtype E V3 loop.
    Sato H; Kato K; Takebe Y
    Virology; 1999 May; 257(2):491-501. PubMed ID: 10329559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural variation in the amino acid sequence around the HIV type 1 glycoprotein 160 cleavage site and its effect on cleavability, subunit association, and membrane fusion.
    Adams O; Schaal H; Scheid A
    AIDS Res Hum Retroviruses; 2000 Sep; 16(13):1235-45. PubMed ID: 10957721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Presence of multiple genetic subtypes of human immunodeficiency virus type 1 proviruses in Uganda.
    Bruce C; Clegg C; Featherstone A; Smith J; Biryahawaho B; Downing R; Oram J
    AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1543-50. PubMed ID: 7888209
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic and functional analysis of a set of HIV-1 envelope genes obtained from biological clones with varying syncytium-inducing capacities.
    Andeweg AC; Groenink M; Leeflang P; de Goede RE; Osterhaus AD; Tersmette M; Bosch ML
    AIDS Res Hum Retroviruses; 1992 Oct; 8(10):1803-13. PubMed ID: 1457193
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of the HIV type 1 glycoprotein 120 V3 loop in determining coreceptor usage.
    Verrier F; Borman AM; Brand D; Girard M
    AIDS Res Hum Retroviruses; 1999 May; 15(8):731-43. PubMed ID: 10357469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics of HIV-1 env V3 loop sequences for subtype A1 variant spread in Eastern Europe.
    Papuashvili MN; Novokhatsky AS; Shcherbakova TI
    Infect Genet Evol; 2005 Jan; 5(1):45-53. PubMed ID: 15567138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A hidden region in the third variable domain of HIV-1 IIIB gp120 identified by a monoclonal antibody.
    Laman JD; Schellekens MM; Lewis GK; Moore JP; Matthews TJ; Langedijk JP; Meloen RH; Boersma WJ; Claassen E
    AIDS Res Hum Retroviruses; 1993 Jul; 9(7):605-12. PubMed ID: 8369165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.